The latest update is out from BioNano Genomics ( (BNGO) ).
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Bionano Genomics has announced a registered direct offering involving the sale of common stock and warrants to raise approximately $10 million, with potential additional proceeds of $20 million from the exercise of warrants. The funds raised will be used for general corporate purposes, including research and development, working capital, and debt repayment, positioning the company strategically within its industry.
More about BioNano Genomics
Bionano Genomics is a provider of genome analysis solutions that enable researchers and clinicians to explore complex biological and medical questions. Their offerings include optical genome mapping solutions, diagnostic services, and software for genome analysis, as well as nucleic acid extraction and purification solutions using proprietary technology. The company focuses on applications in basic, translational, and clinical research.
YTD Price Performance: 23.92%
Average Trading Volume: 5,825,716
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $32.3M
Find detailed analytics on BNGO stock on TipRanks’ Stock Analysis page.
